Skip to main content
Caplight Logo









SphingoTec

SphingoTec

Private
HennigsdorfHealthcare & Life Scienceshttps://www.sphingotec.eu/

Last Round

Series C

Aug 8, 2024

Total Funding Raised

$28.55M

Company Overview

SphingoTec is a diagnostics company that develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biomarker assaysnovel biomarkersin-vitro diagnosticsIVDpoint-of-care diagnosticsPOC diagnosticsbiomarker out-licensingacute care diagnosticscritical care diagnosticspenKidsepsis diagnosticsacute kidney injurykidney function assessmentbio-ADMacute heart failureclinical trial supportNexus IB10endothelial function

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SphingoTec Comparables

Compare SphingoTec with similar companies based on industry and business-model similarity.

SphingoTec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Immunexpress
78%
BioPorto A/S
77%
Inflammatix
72%

SphingoTec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 8, 2024
VC RoundFeb 21, 2024
Growth EquityOct 8, 2018

SphingoTec Investors

Notable investors and investment history

SphingoTec investors
InvestorRounds
Think.HealthSeries C
HBM Healthcare InvestmentsSeries C, Growth Equity
NRW.BankSeries C
Brandenburg KapitalSeries C
Wellington PartnersSeries C, Growth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 263% MoM, reaching 2K.

  • Nov 7, 2025

    Monthly visitors grew 562% MoM, from 193 to 1.3K.

SphingoTec Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SphingoTec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SphingoTec's valuation, stock price, and market status.

Firmographic Details

HeadquartersHennigsdorf
Employee Range19
Year Founded2002
Last FundingAug 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?